CATALYST PHARMACEUTICALS INC

Ticker: CPRX CUSIP: 14888U101 Class: Common Stock

Brookstone Capital Management's Holding History (CIK: 0001599584)

Note: Option positions (PUT/CALL) are excluded.

Q3 2024
Shares 33,506 Value ($000) $666 Avg Close $18.54 Range $14.97 - $21.67
Q2 2024
Shares 33,506 Value ($000) $566 Avg Close $15.57 Range $14.47 - $17.03
Q1 2024
Shares 33,506 Value ($000) $534 Avg Close $15.07 Range $13.12 - $17.50
Q4 2023
Shares 33,506 Value ($000) $563 Avg Close $13.67 Range $11.55 - $17.40
Q3 2023
Shares 33,468 Value ($000) $433 Avg Close $13.38 Range $11.59 - $15.59
Q2 2023
Shares 36,907 Value ($000) $455 Avg Close $14.39 Range $11.09 - $18.22
Q1 2023
Shares 33,468 Value ($000) $605 Avg Close $16.50 Range $13.30 - $22.11
Q4 2022
Shares 33,518 Value ($000) $657 Avg Close $15.40 Range $12.08 - $19.78
Q3 2022
Shares 33,469 Value ($000) $415 Avg Close $11.85 Range $6.87 - $17.22
Q2 2021
Shares 16,472 Value ($000) $91 Avg Close $5.16 Range $4.21 - $6.22
Q1 2021
Shares 15,390 Value ($000) $71 Avg Close $3.97 Range $3.27 - $5.05